Literature DB >> 10512725

Differential expression of protein kinase C isoform transcripts in human hematopoietic progenitors undergoing differentiation.

S Oshevski1, M C Le Bousse-Kerdilès, D Clay, Z Levashova, N Debili, N Vitral, C Jasmin, M Castagna.   

Abstract

Protein kinase C (PKC), a key component of the signaling pathways leading to proliferation and differentiation, consists of a family closely related serine/threonine protein kinases. The mRNA expression of these PKC isoforms has been characterized during hematopoietic differentiation. Using the reverse-transcriptase polymerase chain reaction technique, we have analyzed the levels of isoform transcripts in bone marrow CD34(+) hematopoietic progenitors and their progeny differentiated along erythroid, megakaryocyte, or granulocyte/monocyte lineages, upon exposure to growth factors. In contrast with isoforms alpha, beta(I), beta(II), delta, and epsilon, ubiquitously expressed, isoforms theta, eta/L, zeta, and iota/lambda exhibited a lineage-restricted expression. These qualitative changes, which allow to distinguish the erythroid and megakaryocyte phenotypes from the granulocyte/monocyte phenotype, include zeta exclusively upregulated in granulocytes/monocytes and theta, eta/L, and iota/lambda exclusively expressed in megakaryocytes and erythroblasts. In contrast, erythroblasts and megakaryocytes, which supposedly share a common bipotential progenitor, displayed only quantitative changes. These results evidence the selective expression of PKC isoforms at transcriptional and/or posttranscriptional levels in hematopoietic progenitors induced to differentiate, which may suggest a differential contribution of individual isoforms to cellular signaling. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512725     DOI: 10.1006/bbrc.1999.1425

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Differentiation-Associated Expression of Conventional Protein Kinase C Isoforms in Primary Cultures of Bone Marrow Cells Induced by M-CSF and G-CSF.

Authors:  Xiaohua Li; Hong Meng; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-01-01

2.  Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.

Authors:  Gauthami Jalagadugula; Guangfen Mao; Gurpreet Kaur; Danny N Dhanasekaran; A Koneti Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

3.  Protein kinase C δ deficiency enhances megakaryopoiesis and recovery from thrombocytopenia.

Authors:  John C Kostyak; Dheeraj Bhavanasi; Elisabeta Liverani; Steven E McKenzie; Satya P Kunapuli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-30       Impact factor: 8.311

4.  Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation.

Authors:  Ulka Vijapurkar; Neal Fischbach; Weifang Shen; Christian Brandts; David Stokoe; H Jeffrey Lawrence; Corey Largman
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

5.  PDGF receptor activation induces p120-catenin phosphorylation at serine 879 via a PKCalpha-dependent pathway.

Authors:  Meredith V Brown; Patrick E Burnett; Mitchell F Denning; Albert B Reynolds
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

6.  Activation of protein kinase C{eta} by type I interferons.

Authors:  Amanda J Redig; Antonella Sassano; Beata Majchrzak-Kita; Efstratios Katsoulidis; Hui Liu; Jessica K Altman; Eleanor N Fish; Amittha Wickrema; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2009-02-11       Impact factor: 5.157

7.  Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions.

Authors:  Adi Gilboa-Geffen; Gunther Hartmann; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2012-03-16       Impact factor: 5.639

8.  Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.

Authors:  O Uziel; E Fenig; J Nordenberg; E Beery; H Reshef; J Sandbank; M Birenbaum; M Bakhanashvili; R Yerushalmi; D Luria; M Lahav
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

9.  PKCε signalling activates ERK1/2, and regulates aggrecan, ADAMTS5, and miR377 gene expression in human nucleus pulposus cells.

Authors:  Emmanouella Tsirimonaki; Constantinos Fedonidis; Spiros G Pneumaticos; Adamantios A Tragas; Ioannis Michalopoulos; Dimitra Mangoura
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

10.  PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis.

Authors:  John C Kostyak; Elisabetta Liverani; Satya P Kunapuli
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.